These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Characterization and role in autoimmune diseases of the polyclonal B-cell activator produced by T-cells-the helper factor. Teodorescu M Immunol Rev; 1981; 55():155-78. PubMed ID: 6165671 [No Abstract] [Full Text] [Related]
25. New perspectives on immunointervention in autoimmune diseases. Adorini L; Barnaba V; Bona C; Celada F; Lanzavecchia A; Sercarz E; Suciu-Foca N; Wekerle H Immunol Today; 1990 Nov; 11(11):383-6. PubMed ID: 2078289 [No Abstract] [Full Text] [Related]
26. Alterations in T, B, and null cells in children with autoimmune diseases. Strelkauskas AJ; Schauf V; Dray S Clin Immunol Immunopathol; 1976 Nov; 6(3):359-68. PubMed ID: 1086176 [No Abstract] [Full Text] [Related]
28. [Immunosuppression and hematopoietic stem cell transplantation for autoimmune diseases]. Ramón Ed; Espigado I Med Clin (Barc); 2002 Jun; 119(3):96-8. PubMed ID: 12106537 [No Abstract] [Full Text] [Related]
29. Prospects for B-cell-targeted therapy in autoimmune disease. Edwards JC; Cambridge G Rheumatology (Oxford); 2005 Feb; 44(2):151-6. PubMed ID: 15509628 [No Abstract] [Full Text] [Related]
30. Immunological effects of probiotics with special reference to lactobacilli. Vaarala O Clin Exp Allergy; 2003 Dec; 33(12):1634-40. PubMed ID: 14656348 [No Abstract] [Full Text] [Related]
31. [The importance of B cell-T cell interaction in autoimmune diseases]. Iwata S; Tanaka Y Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(5):398-402. PubMed ID: 26725861 [TBL] [Abstract][Full Text] [Related]
32. Lessons for transplant immunosuppression from the usage of cyclosporine in autoimmune diseases. Bach JF Transplant Proc; 1994 Oct; 26(5):3077-81. PubMed ID: 7940966 [No Abstract] [Full Text] [Related]
33. Pathogenic functions of B cells in autoimmune diseases: IFN-γ production joins the criminal gang. Fillatreau S Eur J Immunol; 2015 Apr; 45(4):966-70. PubMed ID: 25727209 [TBL] [Abstract][Full Text] [Related]
34. Understanding what infiltrating cells do in autoimmunity: combination of cellular and molecular approaches. Feldmann M; Londei M; Grubeck-Loebenstein B; De Berardinis P; Leech Z; Turner M; Barrett K; Buchan G; Maini RN Transplant Proc; 1988 Apr; 20(2):311-4. PubMed ID: 3284062 [No Abstract] [Full Text] [Related]
35. International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease. Khosroshahi A; Wallace ZS; Crowe JL; Akamizu T; Azumi A; Carruthers MN; Chari ST; Della-Torre E; Frulloni L; Goto H; Hart PA; Kamisawa T; Kawa S; Kawano M; Kim MH; Kodama Y; Kubota K; Lerch MM; Löhr M; Masaki Y; Matsui S; Mimori T; Nakamura S; Nakazawa T; Ohara H; Okazaki K; Ryu JH; Saeki T; Schleinitz N; Shimatsu A; Shimosegawa T; Takahashi H; Takahira M; Tanaka A; Topazian M; Umehara H; Webster GJ; Witzig TE; Yamamoto M; Zhang W; Chiba T; Stone JH; Arthritis Rheumatol; 2015 Jul; 67(7):1688-99. PubMed ID: 25809420 [No Abstract] [Full Text] [Related]
36. The T-box transcription factor T-bet in immunity and autoimmunity. Peng SL Cell Mol Immunol; 2006 Apr; 3(2):87-95. PubMed ID: 16696895 [TBL] [Abstract][Full Text] [Related]